Repligen (RGEN): No reason to change bullish stance on stock, says Stifel
Tweet Send to a Friend
Stifel analyst Daniel Arias reiterated a Buy rating and $207.00 price target on Repligen (NASDAQ: RGEN).The analyst commented, "The business ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
